Lundbeck AB och Otsuka Pharma Scandinavia AB är separat personuppgiftsansvariga.
Otsuka Pharma Scandinavia AB hanterar eventuella personuppgifter i enlighet med GDPR. Mer information finner du i vår Privacy Policy på www.otsuka-europe.com/se/HCPPrivacyNotice
H. Lundbeck AB hanterar dina personuppgifter i enlighet med sin integritetspolicy som finns att läsa på www.lundbeck.se

This meeting will be a prologue to our annual Schizophrenia Expert meeting that will be arranged, hopefully live, in October 2021. We will focus on the necessity of preventing relapse in patients with schizophrenia and the implications this will have in their lives. The Swedish study from Danderyd will show more detailed information on how the usage of long-active antipsychotics prevents relapses, but also the patient’s inclination to its use.

Please note *Mandatory = name, e-mail.